cmeadminuser

Assuring a Sterile Environment Launched in 2008 by the United States Pharmacopeial Convention (USP), General Chapter 797 is, in part, a response to the history of deaths and injuries attributed to contaminated pharmaceuticals. From the deaths of four patients in Nebraska in 1990 to an FDA announced recall by U.S. Compounding, Inc. of sterile compounded products in 2015, a Timeline […]

Deanna Kiska, Ph.D. is the new President of U.S. Micro-Solutions, Inc., an environmental microbiology laboratory founded in 1996 by her father, Herb Layman. Deanna received her doctorate degree in Microbiology from the Medical College of Virginia and completed a fellowship in Clinical Microbiology at the University of North Carolina Chapel Hill. She is board certified in Medical Microbiology. She was […]

The Centers for Disease Control have collected data on Legionnaires’ disease from 21 jurisdictions in the United States (20 states and 1 large metropolitan area).  Access full report here. Legionnaires’ disease is widespread in U.S. health care facilities. Definite health care-associated Legionnaires’ disease cases were reported by the majority (76%) of the 21 jurisdictions, including 72 facilities with 1-6 cases […]

More than 20% of Legionnaires’ disease cases reported to the Centers for Disease Control are associated with travel, which includes travel on cruise ships.  Contaminated hot tubs are the most commonly implicated shipboard sources; however, potable water systems have also been linked to transmission. From 1977-2012, there were 84 ship-associated cases of Legionnaires disease with 8 ships experiencing outbreaks of […]